Researchers identify three drugs as possible therapeutics for COVID-19
Based on virtual and in vitro antiviral screening that began in the earlier months of the COVID-19 pandemic, the researchers led at UTHSC by Colleen Jonsson, PhD, identified zuclopenthixol, nebivolol, and amodiaquine as promising therapeutics for the virus in its early stages. Dr. Jonsson is a professor and the Endowed Van Vleet Chair of Excellence… Read More